Sonia-Maria Poli

Title: The Innovative Contributions of Sonia-Maria Poli

Introduction

Sonia-Maria Poli is a notable inventor based in Onex-Ge, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that modulate metabotropic glutamate receptors. With a total of two patents to his name, his work is recognized for its potential impact on treating central nervous system disorders.

Latest Patents

Sonia-Maria Poli's latest patents include innovative compounds that serve as modulators of metabotropic glutamate receptors, specifically subtype 5 (mGluR5). The first patent describes novel alkynyl derivatives that are useful for treating various disorders influenced by mGluR5 receptors. The second patent reiterates the same compounds, emphasizing their role in addressing central nervous system disorders. These inventions highlight the therapeutic potential of his research in improving health outcomes.

Career Highlights

Sonia-Maria Poli is currently associated with Addex Pharma, S.A., a company dedicated to advancing drug discovery and development. His work at Addex Pharma has positioned him as a key player in the pharmaceutical industry, contributing to innovative solutions for complex medical challenges.

Collaborations

Sonia-Maria Poli collaborates with talented professionals such as Anne-Sophie Bessis and Christelle Bolea. These partnerships enhance the research and development efforts at Addex Pharma, fostering an environment of innovation and creativity.

Conclusion

Sonia-Maria Poli's contributions to the field of pharmaceuticals through his patents and collaborations underscore his commitment to advancing medical science. His work has the potential to significantly impact the treatment of central nervous system disorders, showcasing the importance of innovation in healthcare.